BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19004007)

  • 1. Genomic instability and histone H3 phosphorylation induction by the Ras-mitogen activated protein kinase pathway in pancreatic cancer cells.
    Espino PS; Pritchard S; Heng HH; Davie JR
    Int J Cancer; 2009 Feb; 124(3):562-7. PubMed ID: 19004007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin modification of the trefoil factor 1 gene in human breast cancer cells by the Ras/mitogen-activated protein kinase pathway.
    Espino PS; Li L; He S; Yu J; Davie JR
    Cancer Res; 2006 May; 66(9):4610-6. PubMed ID: 16651411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased genomic instability and altered chromosomal protein phosphorylation timing in HRAS-transformed mouse fibroblasts.
    Dunn KL; He S; Wark L; Delcuve GP; Sun JM; Yu Chen H; Mai S; Davie JR
    Genes Chromosomes Cancer; 2009 May; 48(5):397-409. PubMed ID: 19191262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ser-10 phosphorylation of histone H3 and immediate early gene expression in oncogene-transformed mouse fibroblasts.
    Strelkov IS; Davie JR
    Cancer Res; 2002 Jan; 62(1):75-8. PubMed ID: 11782362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen- and stress-activated protein kinase 1 activity and histone h3 phosphorylation in oncogene-transformed mouse fibroblasts.
    Drobic B; Espino PS; Davie JR
    Cancer Res; 2004 Dec; 64(24):9076-9. PubMed ID: 15604275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of transcription factor promoter regions by low-dose genistein through mitogen-activated protein kinase and mitogen-and-stress activated kinase 1 nongenomic signaling.
    Yu L; Ham K; Gao X; Castro L; Yan Y; Kissling GE; Tucker CJ; Flagler N; Dong R; Archer TK; Dixon D
    Cell Commun Signal; 2016 Aug; 14(1):18. PubMed ID: 27582276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
    Dunn KL; Espino PS; Drobic B; He S; Davie JR
    Biochem Cell Biol; 2005 Feb; 83(1):1-14. PubMed ID: 15746962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the Ras-MAPK pathway leads to independent phosphorylation of histone H3 on serine 10 and 28.
    Dunn KL; Davie JR
    Oncogene; 2005 May; 24(21):3492-502. PubMed ID: 15735677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2.
    Dyson MH; Thomson S; Inagaki M; Goto H; Arthur SJ; Nightingale K; Iborra FJ; Mahadevan LC
    J Cell Sci; 2005 May; 118(Pt 10):2247-59. PubMed ID: 15870105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts.
    Chadee DN; Hendzel MJ; Tylipski CP; Allis CD; Bazett-Jones DP; Wright JA; Davie JR
    J Biol Chem; 1999 Aug; 274(35):24914-20. PubMed ID: 10455166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effect of K-ras gene mutation on epidermal growth factor receptor signal transduction in PANC-1 pancreatic carcinoma cells.
    Watanabe M; Nobuta A; Tanaka J; Asaka M
    Int J Cancer; 1996 Jul; 67(2):264-8. PubMed ID: 8760597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H1(S)-3 phosphorylation in Ha-ras oncogene-transformed mouse fibroblasts.
    Chadee DN; Peltier CP; Davie JR
    Oncogene; 2002 Dec; 21(55):8397-403. PubMed ID: 12466960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Raf-1 in human pancreatic adenocarcinoma.
    Berger DH; Jardines LA; Chang H; Ruggeri B
    J Surg Res; 1997 Apr; 69(1):199-204. PubMed ID: 9202670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
    Jin K; Park S; Ewton DZ; Friedman E
    Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration.
    Giehl K; Skripczynski B; Mansard A; Menke A; Gierschik P
    Oncogene; 2000 Jun; 19(25):2930-42. PubMed ID: 10871844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J; Niu J; Li M; Chiao PJ; Tsao MS
    Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38-MAPK/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer.
    Khan SA; Amnekar R; Khade B; Barreto SG; Ramadwar M; Shrikhande SV; Gupta S
    Clin Epigenetics; 2016; 8(1):88. PubMed ID: 27588146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
    Matsuda K; Idezawa T; You XJ; Kothari NH; Fan H; Korc M
    Cancer Res; 2002 Oct; 62(19):5611-7. PubMed ID: 12359775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSK1 and MSK2 mediate mitogen- and stress-induced phosphorylation of histone H3: a controversy resolved.
    Davie JR
    Sci STKE; 2003 Aug; 2003(195):PE33. PubMed ID: 12915720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.